Evidence map›Paper›PMID 39594129›Full record

ReviewDiagnostics (Basel, Switzerland)2024

Gut Microbiome and Carotid Artery Intima-Media Thickness: A Narrative Review of the Current Scenario.

Barbara Pala, Giuliano Tocci, Giulia Nardoianni, Emanuele Barbato, Amedeo Amedei

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Barbara PalaDivision of Cardiology, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, University of Rome Sapienza, 00189 Rome, Italy.ORCID 0000-0002-7359-4028
Giuliano TocciDivision of Cardiology, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, University of Rome Sapienza, 00189 Rome, Italy.ORCID 0000-0002-0635-4921
Giulia NardoianniDivision of Cardiology, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, University of Rome Sapienza, 00189 Rome, Italy.ORCID 0000-0001-6861-6870
Emanuele BarbatoDivision of Cardiology, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, University of Rome Sapienza, 00189 Rome, Italy.
Amedeo AmedeiSOD of Interdisciplinary Internal Medicine, Azienda Ospedaliera Universitaria Careggi (AOUC), 50134 Florence, Italy.ORCID 0000-0002-6797-9343

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Up to the last update, the gut microbiome (GM) had been associated with a different physiologic host process, including those affecting cardiovascular health. The carotid intima-media thickness (IMT) is an indicator of atherosclerosis and cardiovascular risk. The GM influence on atherosclerosis progression has garnered growing attention in recent years but the consensus in subclinical atherosclerosis remains elusive. The aim of this narrative review is to investigate the connection between the GM and carotid IMT, encompassing mechanisms like the microbiome impact on metabolite production, and systemic inflammation, and its effects on endothelial function. The literature analysis revealed that the GM appears to exert an influence on carotid IMT development, likely through mechanisms involving metabolites' production, systemic inflammation, and endothelial function modulation. Additional research, however, is needed to finely elucidate the relationship between the GM and atherosclerosis. Specifically, more extensive studies are required to pinpoint individuals at the highest risk of developing atherosclerosis based on their GM composition. This will facilitate the enhancement and optimization of cardiovascular disease prevention strategies and enable the treatments' customization for each patient. Further investigations are required to refine patient outcomes in the context of probiotics and other interventions aimed at improving microbiome composition and function.

Indexed as

carotid atherosclerosiscarotid plaquesgut microbiomeintima-media thicknessultrasound

Identifiers

PMID39594129
PMCPMC11592993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.